Skip to main content
Top
Published in: Archives of Virology 10/2013

01-10-2013 | Original Article

A simple and fast system for cloning influenza A virus gene segments into pHW2000- and pCAGGS-based vectors

Authors: Volker Czudai-Matwich, Markus Schnare, Olaf Pinkenburg

Published in: Archives of Virology | Issue 10/2013

Login to get access

Abstract

The reverse genetics system for influenza A viruses described by Hoffmann et al. (Virology 267(2):310–317, 2000, Proc Natl Acad Sci USA 97(11):6108–6113, 2000, ArchVirol 146(12):2275–2289, 2001) is one of the most commonly used. However, this cloning strategy is rather time-consuming and lacks a selection marker to identify positive clones carrying viral genes. We report here the optimization of the cloning protocol of viral genes into pHW2000 by (i) introducing a selection marker and (ii) simplifying the cloning strategy: now the cloning reaction takes only a few minutes and, in addition, is independent of internal restriction sites for BsmBI/Esp3I, BsaI or AarI. In order to accelerate the whole cloning protocol for the generation of recombinant viruses, we first introduced a lacP/Z-element (lac-promoter/lacZα-fragment) between the two BsmBI sites of pHW2000 to allow selection of positive clones by blue/white screening. Then we optimized the digestion/ligation-protocol: In our system, enzymatic digestion and ligation of PCR products into the vector is performed in a single “one-tube” reaction. Due to this strategy, time and material consumption is reduced by a great amount, as vector and cDNA do not have to be digested and purified prior to the ligation. Therefore, this one-tube reaction yields positive clones with high efficiency and fidelity, again saving time and material, which were formerly required for screening and analyzing clones. Finally, to add more versatility to the system, we also created an entry vector based on TA-cloning. This entry vector provides several advantages: inserted genes can easily be modified, e.g., by site-directed mutagenesis or tag attachment, and then subcloned into pHW2000 or other plasmids containing a similar cloning site (e.g., our modified pCAGGS-Esp-blue) by the same rapid and reliable one-tube reaction protocol described here. In fact, the presented protocol is suitable to be adapted to other reverse genetics systems (e.g., those for members of the order Mononegavirales or the family Bunyaviridae) or cloning of genes in general.
Literature
1.
go back to reference Hoffmann E et al (2000) “Ambisense” approach for the generation of influenza A virus: vRNA and mRNA synthesis from one template. Virology 267(2):310–317PubMedCrossRef Hoffmann E et al (2000) “Ambisense” approach for the generation of influenza A virus: vRNA and mRNA synthesis from one template. Virology 267(2):310–317PubMedCrossRef
2.
go back to reference Hoffmann E et al (2000) A DNA transfection system for generation of influenza A virus from eight plasmids. Proc Natl Acad Sci USA 97(11):6108–6113PubMedCrossRef Hoffmann E et al (2000) A DNA transfection system for generation of influenza A virus from eight plasmids. Proc Natl Acad Sci USA 97(11):6108–6113PubMedCrossRef
3.
go back to reference Hoffmann E et al (2001) Universal primer set for the full-length amplification of all influenza A viruses. Arch Virol 146(12):2275–2289PubMedCrossRef Hoffmann E et al (2001) Universal primer set for the full-length amplification of all influenza A viruses. Arch Virol 146(12):2275–2289PubMedCrossRef
4.
go back to reference Neumann G et al (1999) Generation of influenza A viruses entirely from cloned cDNAs. Proc Natl Acad Sci USA 96(16):9345–9350PubMedCrossRef Neumann G et al (1999) Generation of influenza A viruses entirely from cloned cDNAs. Proc Natl Acad Sci USA 96(16):9345–9350PubMedCrossRef
5.
go back to reference Fodor E et al (1999) Rescue of influenza A virus from recombinant DNA. J Virol 73(11):9679–9682PubMed Fodor E et al (1999) Rescue of influenza A virus from recombinant DNA. J Virol 73(11):9679–9682PubMed
6.
go back to reference de Wit E et al (2007) A reverse-genetics system for Influenza A virus using T7 RNA polymerase. J Gen Virol 88(Pt 4):1281–1287PubMedCrossRef de Wit E et al (2007) A reverse-genetics system for Influenza A virus using T7 RNA polymerase. J Gen Virol 88(Pt 4):1281–1287PubMedCrossRef
7.
go back to reference Zobel A, Neumann G, Hobom G (1993) RNA polymerase I catalysed transcription of insert viral cDNA. Nucleic Acids Res 21(16):3607–3614PubMedCrossRef Zobel A, Neumann G, Hobom G (1993) RNA polymerase I catalysed transcription of insert viral cDNA. Nucleic Acids Res 21(16):3607–3614PubMedCrossRef
8.
go back to reference Selmer T, Pinkenburg O (2008) WO2008095927 (A1) Method of cloning at least one nucleic acid molecule of interest using type IIs restriction endonucleases, and corresponding cloning vectors, kits and system using type IIs restriction endonucleases. Patent Assignee: Philipps-University Marburg; Inventors: Selmer T, Pinkenburg O Selmer T, Pinkenburg O (2008) WO2008095927 (A1) Method of cloning at least one nucleic acid molecule of interest using type IIs restriction endonucleases, and corresponding cloning vectors, kits and system using type IIs restriction endonucleases. Patent Assignee: Philipps-University Marburg; Inventors: Selmer T, Pinkenburg O
9.
go back to reference Engler C, Kandzia R, Marillonnet S (2008) A one pot, one step, precision cloning method with high throughput capability. PLoS One 3(11):e3647PubMedCrossRef Engler C, Kandzia R, Marillonnet S (2008) A one pot, one step, precision cloning method with high throughput capability. PLoS One 3(11):e3647PubMedCrossRef
10.
go back to reference Niwa H, Yamamura K, Miyazaki J (1991) Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108(2):193–199PubMedCrossRef Niwa H, Yamamura K, Miyazaki J (1991) Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108(2):193–199PubMedCrossRef
11.
go back to reference Holton TA, Graham MW (1991) A simple and efficient method for direct cloning of PCR products using ddT-tailed vectors. Nucleic Acids Res 19(5):1156PubMedCrossRef Holton TA, Graham MW (1991) A simple and efficient method for direct cloning of PCR products using ddT-tailed vectors. Nucleic Acids Res 19(5):1156PubMedCrossRef
12.
go back to reference Inoue H, Nojima H, Okayama H (1990) High efficiency transformation of Escherichia coli with plasmids. Gene 96(1):23–28PubMedCrossRef Inoue H, Nojima H, Okayama H (1990) High efficiency transformation of Escherichia coli with plasmids. Gene 96(1):23–28PubMedCrossRef
13.
go back to reference Zhou MY, Gomez-Sanchez CE (2000) Universal TA cloning. Curr Issues Mol Biol 2(1):1–7PubMed Zhou MY, Gomez-Sanchez CE (2000) Universal TA cloning. Curr Issues Mol Biol 2(1):1–7PubMed
14.
go back to reference Stech J et al (2008) Rapid and reliable universal cloning of influenza A virus genes by target-primed plasmid amplification. Nucleic Acids Res 36(21):e139PubMedCrossRef Stech J et al (2008) Rapid and reliable universal cloning of influenza A virus genes by target-primed plasmid amplification. Nucleic Acids Res 36(21):e139PubMedCrossRef
15.
go back to reference Wang S et al (2008) Simplified recombinational approach for influenza A virus reverse genetics. J Virol Methods 151(1):74–78PubMedCrossRef Wang S et al (2008) Simplified recombinational approach for influenza A virus reverse genetics. J Virol Methods 151(1):74–78PubMedCrossRef
16.
go back to reference Zhou B et al (2009) Single-reaction genomic amplification accelerates sequencing and vaccine production for classical and Swine origin human influenza a viruses. J Virol 83(19):10309–10313PubMedCrossRef Zhou B et al (2009) Single-reaction genomic amplification accelerates sequencing and vaccine production for classical and Swine origin human influenza a viruses. J Virol 83(19):10309–10313PubMedCrossRef
17.
go back to reference Geng L et al (2006) A universal cloning vector using vaccinia topoisomerase I. Mol Biotechnol 33(1):23–28PubMed Geng L et al (2006) A universal cloning vector using vaccinia topoisomerase I. Mol Biotechnol 33(1):23–28PubMed
Metadata
Title
A simple and fast system for cloning influenza A virus gene segments into pHW2000- and pCAGGS-based vectors
Authors
Volker Czudai-Matwich
Markus Schnare
Olaf Pinkenburg
Publication date
01-10-2013
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 10/2013
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-013-1697-4

Other articles of this Issue 10/2013

Archives of Virology 10/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.